Showing results (121-130 of 437) with videos related to

Sort By:
Pageof 44
Blood|March 2, 2021
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expressionVikas A Gupta, Benjamin G Barwick, Shannon M Matulis, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2019
SOHO State of the Art Updates and Next Questions: T-Cell-Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor-Modified T Cells and Bispecific T-Cell-Engaging AgentsDeepu Madduri, Madhav V Dhodapkar, Sagar Lonial, et al.
Molecular Cancer Therapeutics|September 15, 2011
The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cellsLiqun Zhao, Ping Yue, Sagar Lonial, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2011
Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literatureAjay Nooka, Pareen J Shenoy, Rajni Sinha, et al.
Acta Haematologica|May 12, 2024
Real-World Risk of Severe Cytopenias in Multiple Myeloma Patients Sequentially Treated with Immunomodulatory DrugsJulie Barberio, Timothy L Lash, Ajay K Nooka, et al.
Experimental Hematology|July 16, 2008
Regulation of alloimmune responses by dendritic cell subsetsSagar Lonial, Claire Torre, Ebenezer David, et al.
Expert Opinion on Biological Therapy|August 18, 2016
Update on elotuzumab, a novel anti-SLAMF7 monoclonal antibody for the treatment of multiple myelomaSagar Lonial, Jonathan Kaufman, Donna Reece, et al.
Vaccine|November 27, 2002
A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responsesJyoti Somani, Sagar Lonial, Hilary Rosenthal, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Spatial multi-omics of multiple myeloma uncovers niche-dependent pro-myeloma and immunosuppressive signaling in the bone marrow and extramedullary lesionsDenis J Ohlstrom, Marina E Michaud, Mojtaba Bakhtiari, et al.
Blood Cancer Journal|May 27, 2021
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM)Sagar Lonial, Ajay K Nooka, Praneetha Thulasi, et al.
Pageof 44